Anna Maria Granato

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Andrea Casadei‐Gardini, Luca Faloppi, Serena De Matteis et al. · European Journal of Cancer · 2017 · 92 citations · Full text

Oncology, Hepatology, Hepatocellular Carcinoma +9

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

Laura Ridolfi, Massimiliano Petrini, Anna Maria Granato et al. · Journal of Translational Medicine · 2013 · 67 citations · Full text

Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?

Anna Maria Granato, Oriana Nanni, Fabio Falcini et al. · Breast Cancer Research · 2003 · 58 citations · Full text

Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study

Annalisa Volpi, Franca De Paola, Oriana Nanni et al. · Breast Cancer Research and Treatment · 2000 · 53 citations

Prognostic Biomarkers, Breast Oncology, Oncology +8

Role of biological markers in the clinical outcome of colon cancer

Oriana Nanni, Annalisa Volpi, Giovanni Luca Frassineti et al. · British Journal of Cancer · 2002 · 51 citations · Full text